Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CNI-1493 attenuates hemodynamic and cytokine responses to LPS in rats

Jan. 7, 1999

S-19777: novel ET antagonist of microbial origin

Jan. 7, 1999

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Vascular-selective potassium channel openers designed at Kanebo

Dec. 30, 1998

U.S. patent improves proprietary position of Alexion in C5 complement inhibition

Dec. 30, 1998

FDA gives go-ahead for first human study of VEGF-2 gene therapy

Dec. 30, 1998

Myocardial protective effects of JTV-519 demonstrated in isolated rat hearts

Dec. 30, 1998

Cardiovascular and Renal Drugs Advisory Committee meets in late January to discuss two NDAs

Dec. 29, 1998

Knoll and Hoechst Marion Roussel to codevelop treatment for CHF and hypertension

Dec. 23, 1998

Millennium delivers two additional drug targets for screening to Lilly

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...